Spark Therapeutics, Inc. Contracts & Agreements
59 Contracts & Agreements
- Business Finance (18 contracts)
- Business Operations (5)
- Human Resources (13)
- Intellectual Property (3)
- Mergers & Acquisitions (1)
- Real Estate (4)
- Uncategorized (15)
- Consulting Agreement between the Registrant and John P. Furey (Filed With SEC on May 10, 2019)
- Amendment No. 1, dated October 1, 2018, to the Lease Agreement dated November 20, 2017 between the Registrant and Brandywine 3025 Market, LP (Filed With SEC on February 28, 2019)
- License Agreement Amendment dated March 10, 2016 (effective November 23, 2015) amending and superseding the License Agreement between the Company and the Children's Hospital of... (Filed With SEC on February 28, 2019)
- Agreement and Plan of Merger, dated as of February 22, 2019, among Spark Therapeutics, Inc., Roche Holdings, Inc. and 022019 Merger Subsidiary, Inc (Filed With SEC on February 25, 2019)
- Dedicated Manufacturing and Commercial Supply Agreement, dated August 3, 2018, between the Registrant and Brammer Bio MA, LLC (Filed With SEC on November 6, 2018)
- Credit Agreement, dated July 3, 2018, between the Registrant and Wells Fargo Bank, National Association (Filed With SEC on November 6, 2018)
- Cash Collateral Agreement, dated July 3, 2018, between the Registrant and Wells Fargo Bank, National Association (Filed With SEC on November 6, 2018)
- Asset Purchase Agreement, dated April 30, 2018 between the Registrant and Jazz Pharmaceuticals Ireland Limited (Filed With SEC on August 8, 2018)
- Manufacture and Supply Agreement, dated February 16, 2018, between the Registrant and Pfizer (Filed With SEC on May 8, 2018)
- Lease Agreement, dated as of November 20, 2017, between the Registrant and Brandywine 3025 Market, LP (Filed With SEC on February 27, 2018)
- Amendment No. 2, dated November 6, 2017, to the License Agreement dated December 6, 2014 between the Registrant and Pfizer (Filed With SEC on February 27, 2018)
- Supply Agreement, dated January 24, 2018, between the Registrant and Novartis Pharma AG (Filed With SEC on February 27, 2018)
- License and Commercialization Agreement dated January 24, 2018 between the Registrant and Novartis Pharma AG (Filed With SEC on February 27, 2018)
- SPARK THERAPEUTICS, INC. 4,605,264 Shares of Common Stock, par value $0.001 per share Underwriting Agreement (Filed With SEC on August 4, 2017)
- Exhibit 10.1 Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on August 2, 2017)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. LICENSE AND OPTION AGREEMENT by and between... (Filed With SEC on February 28, 2017)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. Exhibit 10.1 AMENDMENT #1 to License Agreement (Filed With SEC on August 10, 2016)
- EMPLOYMENT AGREEMENT (Filed With SEC on August 10, 2016)
- SPARK THERAPEUTICS, INC. 3,500,000 Shares of Common Stock, par value $0.001 per share Underwriting Agreement (Filed With SEC on June 15, 2016)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on March 14, 2016)
- AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on March 14, 2016)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. LICENSE AGREEMENT - AMENDMENT THREE (Filed With SEC on March 14, 2016)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. Amendment No.1 to Master Research Services... (Filed With SEC on March 14, 2016)
- LEASE by and between WEXFORD-UCSC II, LP, a Delaware limited partnership and SPARK THERAPEUTICS, INC., a Delaware corporation LEASE (Filed With SEC on March 14, 2016)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. LICENSE AGREEMENT AMENDMENT (Filed With SEC on March 14, 2016)
- SPARK THERAPEUTICS, INC. Sharesof Common Stock, par value $0.001 per share Underwriting Agreement (Filed With SEC on December 14, 2015)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. AMENDMENT NO. 1 TO SERVICES AGREEMENT BETWEEN... (Filed With SEC on November 6, 2015)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. LICENSE AGREEMENT AMENDMENT No. 4 (Filed With SEC on November 6, 2015)
- Confidential Materials omitted and filedseparately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on May 11, 2015)
- SPARK THERAPEUTICS, INC. []Shares of Common Stock, par value $0.001 per share Underwriting Agreement (Filed With SEC on January 20, 2015)
- Spark Therapeutics, Inc. 2015STOCK INCENTIVE PLAN (Filed With SEC on January 20, 2015)
- SPARK THERAPEUTICS, INC. INCENTIVE STOCK OPTION AGREEMENT (Filed With SEC on January 20, 2015)
- SPARK THERAPEUTICS, INC. NONQUALIFIED STOCK OPTION AGREEMENT (Filed With SEC on January 20, 2015)
- SPARK THERAPEUTICS, INC. 2015EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on January 20, 2015)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on January 20, 2015)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on January 20, 2015)
- AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on January 20, 2015)
- AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on January 20, 2015)
- EMPLOYMENT AGREEMENT (Filed With SEC on January 20, 2015)
- EMPLOYMENT AGREEMENT (Filed With SEC on January 20, 2015)
- INDEMNIFICATION AGREEMENT (Filed With SEC on January 20, 2015)
- Common Share Membership Agreement (Filed With SEC on December 30, 2014)
- INVESTORS RIGHTS AGREEMENT TABLE OF CONTENTS (Filed With SEC on December 30, 2014)
- 2014 STOCK INCENTIVE PLAN OF SPARK THERAPEUTICS,INC. TABLE OF CONTENTS (Filed With SEC on December 30, 2014)
- SPARK THERAPEUTICS, INC. INCENTIVE STOCK OPTION AGREEMENT GRANTED UNDER 2014 STOCK INCENTIVE PLAN (Filed With SEC on December 30, 2014)
- SPARK THERAPEUTICS INC. NONSTATUTORY STOCK OPTION AGREEMENT GRANTED UNDER 2014 STOCK INCENTIVE PLAN (Filed With SEC on December 30, 2014)
- SPARK THERAPEUTICS, INC. RESTRICTED STOCK AGREEMENT GRANTED UNDER 2014 STOCK INCENTIVE PLAN (Filed With SEC on December 30, 2014)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on December 30, 2014)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on December 30, 2014)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on December 30, 2014)
- SERVICES AGREEMENT (Filed With SEC on December 30, 2014)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. LICENSE AGREEMENT (Filed With SEC on December 30, 2014)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on December 30, 2014)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on December 30, 2014)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on December 30, 2014)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on December 30, 2014)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on December 30, 2014)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on December 30, 2014)
- LEASE by and between WEXFORD-UCSC 3737, LLC, a Delaware limited liability company and SPARKTHERAPEUTICS, LLC, a Delaware limited liability company TABLE OF CONTENTS (Filed With SEC on December 30, 2014)
